Symbols

IXHL

Incannex Healthcare·NASDAQ

--(--)

Signals Analysis

Bullish signal 2

Bearish signal 0

Ample Liquidity

High Gross Profit Margin

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About IXHL

Incannex Healthcare Inc.

A company that develops combinations of synthetic cannabinoids and psychedelic agents

Industry

Pharmaceutical

Established Date

Listing Date

02/28/2022

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

06-30

Website

www.incannex.com

Security Type

Common stock

Office address

Suite 105, 8 Century Circuit Norwest, NSW 2153, Australia

Business

Introduction

Incorporated in Delaware in July 2023, Incannex Healthcare Inc., is a clinical-stage biopharmaceutical company focused on the development of innovative medicines for patients with severe chronic diseases and unmet medical needs. The company's product line includes drug candidates for diseases such as obstructive sleep apnea, generalized anxiety disorder and inflammatory diseases, making it a developer of innovative treatments in the biopharmaceutical industry.

Company Financials

EPS

IXHL has released its 2025 Q3 earnings. EPS was reported at -0.2, versus the expected -0.46, beating expectations. The chart below visualizes how IXHL has performed over recent quarters, highlighting trends in earnings surprises.